Get started
Author

Ana Rosa Raimondi

Dissecting the Akt/Mammalian Target of Rapamycin Signaling Network: Emerging Results from the Head and Neck Cancer Tissue Array Initiative
2007 · Alfredo A. Molinolo, Stephen M. Hewitt, et al. · Clinical Cancer Research · 243
Rapamycin Prevents Early Onset of Tumorigenesis in an Oral-Specific K- ras and p53 Two-Hit Carcinogenesis Model
2009 · Ana R. Raimondi, Alfredo Molinolo, et al. · Cancer Research · 88
PDF
An experimental model to demonstrate the carcinogenic action of oral chronic traumatic ulcer
2004 · Miguel Angel Pérez, Ana Rosa Raimondi, et al. · Journal of Oral Pathology and Medicine · 66
Rapid Development of Salivary Gland Carcinomas upon Conditional Expression of K-ras Driven by the Cytokeratin 5 Promoter
2006 · Ana R. Raimondi, Lynn Vitale-Cross, et al. · American Journal Of Pathology · 41
PDF
Impairing squamous differentiation by Klf4 deletion is sufficient to initiate tongue carcinoma development upon K- Ras activation in mice
2013 · Marianela Abrigo, Romina Alvarez, et al. · Carcinogenesis · 31
PDF
Ploidy analysis of field cancerization and cancer development in the hamster cheek pouch carcinogenesis model
2005 · A. Raimondi, R. Cabrini, et al. · Journal of Oral Pathology and Medicine · 29
RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer
2023 · Natalia B Fernández, Sofía M Sosa, et al. · Cells · 21
The alkynylphosphonate analogue of calcitriol EM1 has potent anti-metastatic effects in breast cancer
2015 · María J. Ferronato, Diego J. Obiol, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 17
PDF
Oral‐specific ablation of Klf4 disrupts epithelial terminal differentiation and increases premalignant lesions and carcinomas upon chemical carcinogenesis
2015 · María L. Paparella, Marianela Abrigo, et al. · Journal of Oral Pathology and Medicine · 15
PDF
Fibroblast growth factor‐2 expression during experimental oral carcinogenesis. Its possible role in the induction of pre‐malignant fibrosis
2006 · A. R. Raimondi, A. A. Molinolo, et al. · Journal of Oral Pathology and Medicine · 13
A major role for Nrf2 transcription factors in cell transformation by KSHV encoded oncogenes
2022 · Daiana Sapochnik, Ana R. Raimondi, et al. · Frontiers in Oncology · 8
PDF
Angiogenesis in potentially malignant lesions and carcinomas during experimental oral carcinogenesis: a preliminary study in the hamster cheek pouch.
2014 · Romina F Aromando, Ana R Raimondi, et al. · PubMed · 8
Modulation by somatostatin of rat parotid salivary secretion stimulated by cholinergic, adrenergic and peptidergic agents
1999 · M.A. Ostuni, A.R. Raimondi, et al. · Archives of Oral Biology · 4
TTP as Tumor Suppressor and Inflammatory Regulator in Oral Carcinogenesis
2025 · D.M. Ferri, M. Ayre, et al. · Journal of Dental Research · 3
Treatment with Angiotensin-(1-7) Prevents Development of Oral Papilloma Induced in K-ras Transgenic Mice
2022 · Carolina Schere-Levy, Melisa Suberbordes, et al. · International Journal of Molecular Sciences · 2
PDF
Quantitative analysis of KLF4 and SOX2 expression in oral carcinomas reveals independent association with oral tongue subsite location and histological grade
2021 · María Luisa Paparella, Dario Martin Ferri, et al. · Cancer Biomarkers · 2
PDF
Supplementary Figure 4 from Tissue Context Shapes Distinct Premalignant Outcomes in an HPV16 E6/E7-Mutant Pik3ca Transgenic Mouse Model
2026 · Marina Ayre, Gonzalo Fernandez-Ugazio, et al.
Figure 4 from Tissue Context Shapes Distinct Premalignant Outcomes in an HPV16 E6/E7-Mutant Pik3ca Transgenic Mouse Model
2026 · Marina Ayre, Gonzalo Fernandez-Ugazio, et al.
Figure 3 from Tissue Context Shapes Distinct Premalignant Outcomes in an HPV16 E6/E7-Mutant Pik3ca Transgenic Mouse Model
2026 · Marina Ayre, Gonzalo Fernandez-Ugazio, et al.
Supplementary Table 1 from Tissue Context Shapes Distinct Premalignant Outcomes in an HPV16 E6/E7-Mutant Pik3ca Transgenic Mouse Model
2026 · Marina Ayre, Gonzalo Fernandez-Ugazio, et al.
Figure 2 from Tissue Context Shapes Distinct Premalignant Outcomes in an HPV16 E6/E7-Mutant Pik3ca Transgenic Mouse Model
2026 · Marina Ayre, Gonzalo Fernandez-Ugazio, et al.
Supplementary Figure 5 from Tissue Context Shapes Distinct Premalignant Outcomes in an HPV16 E6/E7-Mutant Pik3ca Transgenic Mouse Model
2026 · Marina Ayre, Gonzalo Fernandez-Ugazio, et al.
Supplementary Figure 1 from Tissue Context Shapes Distinct Premalignant Outcomes in an HPV16 E6/E7-Mutant Pik3ca Transgenic Mouse Model
2026 · Marina Ayre, Gonzalo Fernandez-Ugazio, et al.
Data from Tissue Context Shapes Distinct Premalignant Outcomes in an HPV16 E6/E7-Mutant Pik3ca Transgenic Mouse Model
2026 · Marina Ayre, Gonzalo Fernandez-Ugazio, et al.
Figure 1 from Tissue Context Shapes Distinct Premalignant Outcomes in an HPV16 E6/E7-Mutant Pik3ca Transgenic Mouse Model
2026 · Marina Ayre, Gonzalo Fernandez-Ugazio, et al.
Works count: 35
Citation count: 591
H-index: 10
I10-index: 10
Year
Topic
Type